Garvan Institute of Medical Research

55 items matching your search terms.

High proportion of rare and compound epidermal growth factor receptor mutations in an Australian population of non-squamous non-small-cell lung cancer: Stone, E.; Allen, H. A.; Saghaie, T.; Abbott, A.; Daniel, R.; Mead, R. S.; Kohonen-Corish, M.; Plit, M.; Morgan, L.;; INTERNAL MEDICINE JOURNAL 44 (12a) :1188-92, 2014

Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database: Thompson, B. A.; Spurdle, A. B.; Plazzer, J. P.; Greenblatt, M. S.; Akagi, K.; Al-Mulla, F.; Bapat, B.; Bernstein, I.; Capella, G.; den Dunnen, J. T.; du Sart, D.; Fabre, A.; Farrell, M. P.; Farrington, S. M.; Frayling, I. M.; Frebourg, T.; Goldgar, D. E.; Heinen, C. D.; Holinski-Feder, E.; Kohonen-Corish, M.; Robinson, K. L.; Leung, S. Y.; Martins, A.; Mol; NATURE GENETICS 46 (2) :107-15, 2014

Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer: Tran, T. N.; Selinger, C. I.; Yu, B.; Ng, C. C.; Kohonen-Corish, M. R.; McCaughan, B.; Kennedy, C.; O'Toole, S. A.; Cooper, W. A.;; JOURNAL OF CLINICAL PATHOLOGY 67 (11) :985-91, 2014

Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer: Yip, P. Y.; Cooper, W. A.; Kohonen-Corish, M. R.; Lin, B. P.; McCaughan, B. C.; Boyer, M. J.; Kench, J. G.; Horvath, L. G.;; JOURNAL OF CLINICAL PATHOLOGY 67 (4) :333-40, 2014

KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer: Kohonen-Corish, M. R.; Tseung, J.; Chan, C.; Currey, N.; Dent, O. F.; Clarke, S.; Bokey, L.; Chapuis, P. H.;; INTERNATIONAL JOURNAL OF CANCER 134 (12) :2820-8, 2014

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization: Selinger, C. I. ; Rogers, T. M. ; Russell, P. A. ; O'Toole, S. ; Yip, P.; Wright, G. M.; Wainer, Z. ; Horvath, L. G. ; Boyer, M. ; McCaughan, B; Kohonen-Corish, M. R. ; Fox, S. ; Cooper, W. A. ; Solomon, B.;; MODERN PATHOLOGY 26 (12) :1545-53, 2013

Sulindac activates NF-kappaB signaling in colon cancer cells: Mladenova, D.: Pangon, L.: Currey, N.: Ng, I.: Musgrove, E. A.: Grey, S. T.: Kohonen-Corish, M. R.:; Cell Communication and Signaling 11 (1) :73, 2013 10.1186/1478-811X-11-73

Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer: Tran, T. N.; Selinger, C. I.; Kohonen-Corish, M. R.; McCaughan, B. C.; Kennedy, C. W.; O'Toole, S. A.; Cooper, W. A.;; LUNG CANCER 81 (3) :462-7, 2013

Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma: Yip, P.Y.; Yu, B.; Cooper, W.; Selinger, C.; Ng, C.C.; Kennedy, C.W.; Kohonen-Corish, M.; McCaughan, B.C.; Trent, R.J.; Boyer, M.J.; Kench, J.; Horvath, L.; O'Toole, S.;; Journal of Thoracic Oncology 8 (4) :408-414, 2013 10.1097/JTO.0b013e318283558e

Beyond the genomics blueprint: the 4th Human Variome Project Meeting, UNESCO, Paris, 2012: Kohonen-Corish, M. R.; Smith, T. D.; Robinson, H. M.;; GENETICS IN MEDICINE 15 (7) :507-12, 2013

EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma: Cooper, W. A.; Yu, B.; Yip, P. Y.; Ng, C. C.; Lum, T.; Farzin, M.; Trent, R. J.; Mercorella, B.; Clarkson, A.; Kohonen-Corish, M. R.; Horvath, L. G.; Kench, J. G.; McCaughan, B.; Gill, A. J.; O'Toole, S. A.;; JOURNAL OF CLINICAL PATHOLOGY 66 (9) :744-8, 2013

GST Pi expression predicts response to adjuvant chemotherapy for Stage C colon cancer.: Jankova, L.; Robertson, G.; Chan, C.; Tan, K.L.; Kohonen-Corish, M.; Fung, C.L.; Clarke, C.; Lin, B.P.C.; Molloy, M.; Chapuis, P.H.; Bokey, L.; Dent, O.F.; Clarke, S.J.; BMC Cancer 12 :196, 2012 10.1186/1471-2407-12-196

Mouse models of inflammatory bowel disease - insights into the mechanisms of inflammation-associated colorectal cancer.: Mladenova, D.; Kohonen-Corish, M.R.J.; IN VIVO 26 (4) :627-46, 2012 26/4/627 [pii]

The PDZ-binding motif of MCC is phosphorylated at position -1 and controls lamellipodia formation in colon epithelial cells.: Pangon, L.; van Kralingen, C.; Abas, M.; Daly, R.J.; Musgrove, E.A.; Kohonen-Corish, M.R.J.; BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (1823) :1058-1067, 2012 10.1016/j.bbamcr.2012.03.011

Mutated in colorectal cancer protein modulates the NF?B pathway.: Sigglekow, N.D.; Pangon, L.; Brummer, T.; Molloy, M.; Hawkins, N.J.; Ward, R.L.; Musgrove, E.A.; Kohonen-Corish, M.; ANTICANCER RESEARCH 32 (1) :73-9, 2012